skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: SU-F-T-580: New Tumor Modeling Using 3D Gel Dosimeter for Brain Stereoctactic Radiotherpy (SRT)

Abstract

Purpose: The purpose of this study is to develop new tumor model using 3D printing with 3D dosimeter for brain stereoctactic radiotherpy (SRT). Methods: BANG{sup 3} polymer gel was prepared and the gel-filled glass vials were irradiated with a 6 MV photon beam to acquire the calibration curve that present the change of R2 (1/T{sub 2}) value with dose. Graded doses from 0 to 12 Gy with an interval of 2 Gy were delivered. A kit for calibration of gel dosimeter and an 2 tumor model phantoms with a spherical shape were produced using a 3D printer with a polylactic acid after its 3D images were created using Autodesk software. 3D printed tumor phantoms and EBT3 films were irradiated to compare with treatment plan. After irradiation, vials for calibration and tumor model phantoms were scanned at 9.4T MRI. The spin-spin relaxation times (T{sub 2}) according to the each dose were calculated to evaluate the dose response. Acquired images were analyzed using an ImageJ. Scanned MRI images of tumor models were transferred treatment planning system and these were registered to the CT images. In all treatment plans, two arc plans (CW and CCW) were designed to deliver 50 Gy for 10more » fractions. For first PTV, treatment plan was accurately designed that 95% of dose to cover 100% of PTV. But 2nd PTV was not intentionally cover 100% of PTV to evaluate the intensity of delivered tumor phantom with polymer gel. We compared the 3D dose distributions obtained from measurements with the 3D printed phantom and calculated with the TPS. Results: 3D printed phantom with a polymer gel was successfully produced. The dose distributions showed qualitatively good agreement among gel, film, and RTP data. Conclusion: A hybrid phantom represents a useful to validate the 3D dose distributions for patient-specific QA.« less

Authors:
; ; ; ; ; ; ;  [1]
  1. Asan Medical Center, Seoul, Seoul (Korea, Republic of)
Publication Date:
OSTI Identifier:
22649155
Resource Type:
Journal Article
Resource Relation:
Journal Name: Medical Physics; Journal Volume: 43; Journal Issue: 6; Other Information: (c) 2016 American Association of Physicists in Medicine; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 61 RADIATION PROTECTION AND DOSIMETRY; BRAIN; CALIBRATION; CAT SCANNING; COMPUTER CODES; DOSEMETERS; GELS; IMAGES; IRRADIATION; NEOPLASMS; NMR IMAGING; PHANTOMS; PHOTON BEAMS; PLANNING; POLYMERS; RADIATION DOSE DISTRIBUTIONS; SIMULATION

Citation Formats

Chang, K, Kim, M, Kwak, J, Kim, S, Ji, Y, Cho, B, Yoon, S, and Lee, S. SU-F-T-580: New Tumor Modeling Using 3D Gel Dosimeter for Brain Stereoctactic Radiotherpy (SRT). United States: N. p., 2016. Web. doi:10.1118/1.4956765.
Chang, K, Kim, M, Kwak, J, Kim, S, Ji, Y, Cho, B, Yoon, S, & Lee, S. SU-F-T-580: New Tumor Modeling Using 3D Gel Dosimeter for Brain Stereoctactic Radiotherpy (SRT). United States. doi:10.1118/1.4956765.
Chang, K, Kim, M, Kwak, J, Kim, S, Ji, Y, Cho, B, Yoon, S, and Lee, S. Wed . "SU-F-T-580: New Tumor Modeling Using 3D Gel Dosimeter for Brain Stereoctactic Radiotherpy (SRT)". United States. doi:10.1118/1.4956765.
@article{osti_22649155,
title = {SU-F-T-580: New Tumor Modeling Using 3D Gel Dosimeter for Brain Stereoctactic Radiotherpy (SRT)},
author = {Chang, K and Kim, M and Kwak, J and Kim, S and Ji, Y and Cho, B and Yoon, S and Lee, S},
abstractNote = {Purpose: The purpose of this study is to develop new tumor model using 3D printing with 3D dosimeter for brain stereoctactic radiotherpy (SRT). Methods: BANG{sup 3} polymer gel was prepared and the gel-filled glass vials were irradiated with a 6 MV photon beam to acquire the calibration curve that present the change of R2 (1/T{sub 2}) value with dose. Graded doses from 0 to 12 Gy with an interval of 2 Gy were delivered. A kit for calibration of gel dosimeter and an 2 tumor model phantoms with a spherical shape were produced using a 3D printer with a polylactic acid after its 3D images were created using Autodesk software. 3D printed tumor phantoms and EBT3 films were irradiated to compare with treatment plan. After irradiation, vials for calibration and tumor model phantoms were scanned at 9.4T MRI. The spin-spin relaxation times (T{sub 2}) according to the each dose were calculated to evaluate the dose response. Acquired images were analyzed using an ImageJ. Scanned MRI images of tumor models were transferred treatment planning system and these were registered to the CT images. In all treatment plans, two arc plans (CW and CCW) were designed to deliver 50 Gy for 10 fractions. For first PTV, treatment plan was accurately designed that 95% of dose to cover 100% of PTV. But 2nd PTV was not intentionally cover 100% of PTV to evaluate the intensity of delivered tumor phantom with polymer gel. We compared the 3D dose distributions obtained from measurements with the 3D printed phantom and calculated with the TPS. Results: 3D printed phantom with a polymer gel was successfully produced. The dose distributions showed qualitatively good agreement among gel, film, and RTP data. Conclusion: A hybrid phantom represents a useful to validate the 3D dose distributions for patient-specific QA.},
doi = {10.1118/1.4956765},
journal = {Medical Physics},
number = 6,
volume = 43,
place = {United States},
year = {Wed Jun 15 00:00:00 EDT 2016},
month = {Wed Jun 15 00:00:00 EDT 2016}
}
  • Purpose: A new 3D gel dosimeter (ClearView™, Modus Medical Systems) was investigated for use as a QA tool for stereotactic radiosurgery (SRS) plans exhibiting high dose gradients and spatially separated treatment targets. The unique feature of this gel dosimeter is the remote processing service provided by Modus Medical Systems. Methods: The gel dosimeters were filled in either 10 cm diameter or 15 cm diameter clear plastic jars. The jars were then shipped in ice-cooled containers to our department for irradiation. Clinical SRS plans for treatment of multiple metastases and plans with simulated concave structures were applied to a CT scanmore » of the gel dosimeter. The gel was irradiated in treatment position using modulated arcs and then returned in the cooled container for processing. The 3D gel dose was compared to the DICOM-RT dose from the treatment plan to assess dosimetric and geometric agreement. Results: There was no discernible difference between the planned and measured dose for dose gradients as high as 10%/mm, which was the highest gradient we evaluated. Geometric agreement for distant metastases separated by 6 cm was within 1.5 mm. Among three identically irradiated gels using a plan intended for nine metastases, the 3%/3mm gamma passing rate was 84.5% with a range of 14.7%, measured over the entire volume of the dosimeter. Regions of larger gamma values correlated with geometric offsets between the planned and measured data. Conclusion: The gel dosimeter exhibits the dosimetric and geometric characteristics necessary for 3D evaluation of treatment plan deliverability. The range of observed gamma passing rates suggests a high sensitivity to geometric registration. With proper management of geometric registration between planned and measured data, this service should enable a radiation oncology department to use 3D dosimetry in end-to-end testing or patient plan delivery QA without the expense of an in-house processing system.« less
  • Purpose: This work presents an end-to-end test using a Gel-Alanine phantom to validate the three-dimensional (3D) dose distribution (DD) delivered by a single isocenter VMAT technique on the simultaneous treatment of multiple brain metastases. Methods: Three cylindrical phantons containing MAGIC-f gel dosimeter were used to measure the 3D DD of a VMAT treatment, the first two were filled with the gel dosimeter (Gel 1 and 2) and the third one was filled with gel and 12 alanine dosimeters distributed along it (Gel 3). Gels 1 and 3 were irradiated and gel 2 was used to map the magnetic resonance imagemore » (MRI) scanner field inomogeneities. A CT scan of gel 3 was used for the VMAT treatment planning and 5 alanine pellets were chosen as lesions, around them a PTV was grown and different dose prescriptions were assigned for each one, varying from 5 to 9Gy. Before treatment, the plan was approved in a QA based on an ionization chamber absolute dose measurement, a radiochromic film planar dose measurement and a portal dosimetry per field verification; and also the phantons positioning were verified by ExacTrac 6D correction and OBI kV Cone Beam CT. The gels were irradiated, the MRIs were acquired 24 hours after irradiation and finally, the alanine dosimeters were analysed in a X-band Electron Spin Resonance spectrometer. Results: The association of the two detectors enabled the 3D dose evaluation by gel and punctually inside target volumes by alanine. In the gamma analyses (3%/3mm) comparing the 5 PTVs’ central images DD with TPS expected DD more than 95% of the points were approved. The alanine absolute dose measurements were in agreement with TPS by less than 5%. Conclusion: The gel-alanine phantom enabled the dosimetric validation of multiple brain metastases treatment using VMAT, being an almost ideal tool for this application. This work is partially supported by FAPESP.« less
  • Purpose: The aim of this dosimetric study was to develop 3D dose verification system for volumetric modulated arc therapy (VMAT) using polyacrylamide-based gel (PAGAT) dosimeter improved the sensitivity by magnesium chloride (MgCl{sub 2}). Methods: PAGAT gel containing MgCl{sub 2} as a sensitizer was prepared in this study. Methacrylic-acid-based gel (MAGAT) was also prepared to compare the dosimetric characteristics with PAGAT gel. The cylindrical glass vials (4 cm diameter, 12 cm length) filled with each polymer gel were irradiated with 6 MV photon beam using Novalis Tx linear accelerator (Varian/BrainLAB). The irradiated polymer gel dosimeters were scanned with Signa 1.5 Tmore » MRI system (GE), and dose calibration curves were obtained using T{sub 2} relaxation rate (R{sub 2} = 1/T{sub 2}). Dose rate (100-600 MU min{sup −1}) and fractionation (1-8 fractions) were varied. In addition, a cubic acrylic phantom (10 × 10 × 10 cm{sup 3}) filled with improved PAGAT gel inserted into the IMRT phantom (IBA) was irradiated with VMAT (RapidArc). C-shape structure was used for the VMAT planning by the Varian Eclipse treatment planning system (TPS). The dose comparison of TPS and measurements with the polymer gel dosimeter was accomplished by the gamma index analysis, overlaying the dose profiles for a set of data on selected planes using in-house developed software. Results: Dose rate and fractionation dependence of improved PAGAT gel were smaller than MAGAT gel. A high similarity was found by overlaying the dose profiles measured with improved PAGAT gel dosimeter and the TPS dose, and the mean pass rate of the gamma index analysis using 3%/3 mm criteria was achieved 90% on orthogonal planes for VMAT using improved PAGAT gel dosimeter. Conclusion: In-house developed 3D dose verification system using improved polyacrylamide-based gel dosimeter had a potential as an effective tool for VMAT QA.« less
  • Purpose: The purpose of this simulation study is to evaluate the proton detectability of gel dosimeters, and estimate the three-dimensional dose distribution of protons in the radiochromic gel and polymer gel dosimeter compared with the dose distribution in water. Methods: The commercial composition ratios of normoxic polymer gel and LCV micelle radiochromic gel were included in this simulation study. The densities of polymer and radiochromic gel were 1.024 and 1.005 g/cm3, respectively. The 50, 80 and 140 MeV proton beam energies were selected. The dose distributions of protons in the polymer and radiochromic gel were simulated using Monte Carlo radiationmore » transport code (MCNPX 2.7.0, Los Alamos Laboratory). The water equivalent depth profiles and the dose distributions of two gel dosimeters were compared for the water. Results: In case of irradiating 50, 80 and 140 MeV proton beam to water phantom, the reference Bragg-peak depths are represented at 2.22, 5.18 and 13.98 cm, respectively. The difference in the water equivalent depth is represented to about 0.17 and 0.37 cm in the radiochromic gel and polymer gel dosimeter, respectively. The proton absorbed doses in the radiochromic gel dosimeter are calculated to 2.41, 3.92 and 6.90 Gy with increment of incident proton energies. In the polymer gel dosimeter, the absorbed doses are calculated to 2.37, 3.85 and 6.78 Gy with increment of incident proton energies. The relative absorbed dose in radiochromic gel (about 0.47 %) is similar to that of water than the relative absorbed dose of polymer gel (about 2.26 %). In evaluating the proton dose distribution, we found that the dose distribution of both gel dosimeters matched that of water in most cases. Conclusion: As the dosimetry device, the radiochromic gel dosimeter has the potential particle detectability and is feasible to use for quality assurance of proton beam therapy beam.« less
  • Purpose: Recently, there has been increased clinical use of stereotactic body radiation therapy (SBRT). SBRT treatments will strongly benefit from in vivo patient dose verification, as any errors in delivery can be more detrimental to the radiobiology of the patient as compared to conventional therapy. In vivo dose measurements, a commercially available quality assurance platform which is able to correlate the delivered dose to the patient’s anatomy and take into account tissue inhomogeneity, is the COMPASS system (IBA Dosimetry, Germany) using a new transmission detector (Dolphin, IBA Dosimetry). In this work, we evaluate a method for in vivo 3D dosemore » reconstruction for SBRT using a new transmission detector, which was developed for in vivo dose verification for intensity-modulated radiation therapy (IMRT). Methods: We evaluated the accuracy of measurement for SBRT using simple small fields (2×2−10×10 cm2), a multileaf collimator (MLC) test pattern, and clinical cases. The dose distributions from the COMPASS were compared with those of EDR2 films (Kodak, USA) and the Monte Carlo simulations (MC). For clinical cases, we compared MC using dose-volume-histograms (DVHs) and dose profiles. Results: The dose profiles from the COMPASS for small fields and the complicated MLC test pattern agreed with those of EDR2 films, and MC within 3%. This showed the COMPASS with Dolphin system showed good spatial resolution and can measure small fields which are required for SBRT. Those results also suggest that COMPASS with Dolphin is able to detect MLC leaf position errors for SBRT. In clinical cases, the COMPASS with Dolphin agreed well with MC. The Dolphin detector, which consists of ionization chambers, provided stable measurement. Conclusion: COMPASS with Dolphin detector showed a useful in vivo 3D dose reconstruction for SBRT. The accuracy of the results indicates that this approach is suitable for clinical implementation.« less